How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Hing (Asafoetida) Market
- By Product Form: Powdered Asafoetida, Granular Asafoetida, Resin Asafoetida, Capsule/Formulated Supplements
- By Purity Grade: Pure Asafoetida, Adulterated/Blended Asafoetida, Food Grade Asafoetida
- By Application: Culinary Use, Pharmaceutical Use, Traditional Medicine, Cosmetic Use
- By Packaging Type: Bulk Packaging, Retail Packaging, Vacuum Sealed Packaging, Glass Jar Packaging
- By Distribution Channel: Direct Sales, Retail Stores, Online Retail, Wholesale Distributors
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Powdered Asafoetida leads By Product Form at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 291 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.175 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.183 →
Full report · locked preview
Everything inside the Hing (Asafoetida) Market report
A complete, evidence-based study - 12 chapters and 122 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Form 4
Purity Grade 3
Application 4
Packaging Type 4
Distribution Channel 4
Companies profiled
Synthite Industries Ltd.
Kancor Ingredients Ltd.
Arjuna Natural Extracts Ltd.
Vidya Herbs Pvt. Ltd.
Herbal Hills Pvt. Ltd.
Indus Organics Pvt. Ltd.
Aarkay Food Products Pvt. Ltd.
Sresta Natural Bioproducts Pvt. Ltd.
Organic India Pvt. Ltd.
Patanjali Ayurved Ltd.
Bafna Pharmaceuticals Pvt. Ltd.
Shree Baidyanath Ayurved Bhawan Pvt. Ltd.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Synthite Industries Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Kancor Ingredients Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Arjuna Natural Extracts Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Vidya Herbs Pvt. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Herbal Hills Pvt. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Indus Organics Pvt. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Aarkay Food Products Pvt. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Sresta Natural Bioproducts Pvt. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Organic India Pvt. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Patanjali Ayurved Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Bafna Pharmaceuticals Pvt. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Shree Baidyanath Ayurved Bhawan Pvt. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Dabur India Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Emami Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Himalaya Drug Company
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,980M by 2033 · 4.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Powdered Asafoetida49.1
- Granular Asafoetida13.3
- Resin Asafoetida21.5
- Capsule/Formulated Supplements16.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,172M → $1,655M · 4.4%
Europe$817.1M → $1,235M · 5.3%
Asia Pacific$746.0M → $1,011M · 3.9%
Latin America$461.8M → $602.9M · 3.4%
Middle East and Africa$355.2M → $483.9M · 3.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.272026
4.272027
4.282028
4.302029
4.312030
4.322031
4.342032
4.352033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Synthite Industries Ltd.18.7
- Kancor Ingredients Ltd.13.0
- Arjuna Natural Extracts Ltd.6.8
- Vidya Herbs Pvt. Ltd.14.3
- Herbal Hills Pvt. Ltd.11.5
- Indus Organics Pvt. Ltd.7.7
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Form28.6%
Purity Grade19.4%
Application13.0%
Packaging Type13.4%
Distribution Channel25.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.2
- Europe24.8
- Asia Pacific20.3
- Latin America12.1
- Middle East and Africa9.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Synthite Industries Ltd. | 84 | 98 | 94 | 99 | 89 | 80 | 91 |
| Kancor Ingredients Ltd. | 73 | 92 | 69 | 71 | 84 | 71 | 77 |
| Arjuna Natural Extracts Ltd. | 77 | 85 | 73 | 76 | 70 | 62 | 74 |
| Vidya Herbs Pvt. Ltd. | 69 | 63 | 62 | 59 | 77 | 69 | 67 |
| Herbal Hills Pvt. Ltd. | 63 | 66 | 62 | 71 | 66 | 73 | 67 |
| Indus Organics Pvt. Ltd. | 54 | 48 | 47 | 70 | 56 | 70 | 58 |
| Aarkay Food Products Pvt. Ltd. | 65 | 62 | 46 | 46 | 40 | 55 | 52 |
| Sresta Natural Bioproducts Pvt. Ltd. | 60 | 49 | 35 | 37 | 38 | 56 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Synthite Industries Ltd.
- Kancor Ingredients Ltd.
- Arjuna Natural Extracts Ltd.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Synthite Industries Ltd. | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Kancor Ingredients Ltd. | ◐ | ✓ | − | ◐ | ◐ | ◐ |
| Arjuna Natural Extracts Ltd. | ◐ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Vidya Herbs Pvt. Ltd. | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| Herbal Hills Pvt. Ltd. | − | ✓ | ◐ | ✓ | ◐ | ✓ |
| Indus Organics Pvt. Ltd. | − | − | ◐ | ✓ | ◐ | ◐ |
| Aarkay Food Products Pvt. Ltd. | ◐ | ✓ | ◐ | − | − | − |
| Sresta Natural Bioproducts Pvt. Ltd. | ◐ | − | − | ◐ | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Synthite Industries Ltd.91
2Kancor Ingredients Ltd.77
3Arjuna Natural Extracts Ltd.74
4Vidya Herbs Pvt. Ltd.67
5Herbal Hills Pvt. Ltd.67
6Indus Organics Pvt. Ltd.58
7Aarkay Food Products Pvt. Ltd.52
8Sresta Natural Bioproducts Pvt. Ltd.46
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Synthite Industries Ltd.
Challenger4
Strong scale, closing on the leaders.
Kancor Ingredients Ltd.Arjuna Natural Extracts Ltd.Vidya Herbs Pvt. Ltd.Herbal Hills Pvt. Ltd.
Contender1
Focused players with pockets of strength.
Indus Organics Pvt. Ltd.
Niche2
Specialists in a single segment or region.
Aarkay Food Products Pvt. Ltd.Sresta Natural Bioproducts Pvt. Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Form in North America, then scale across Hing (Asafoetida) Market — a $170M beachhead inside a $2.87B market.
Beachhead (SOM)$170Mobtainable near-term
Serviceable (SAM)$1.13Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Powdered Asafoetida
Best fit — highest urgency & budget in Product Form.
Economic buyer79 fit
Granular Asafoetida
Strong fit — clear ROI and a fast path to value.
End user64 fit
Resin Asafoetida
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Form in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Purity Grade & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales40%
Partner / channel28%
Digital / self-serve22%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Form leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Hing (Asafoetida) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified20%
Evaluation13%
Closed-won7%
$15.2KCAC
$80KLTV
5.3:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Hing (Asafoetida) Market is a resilient opportunity — $6.18B by 2033, compounding at 5.8%.
TAM · 2025$3.95Btoday
TAM · 2033$6.18Bforecast
CAGR5.8%2027–2033
Cumulative$44.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.18BTotal addressable market
SAM$2.57BServiceable available market
SOM$497MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.8% CAGR
Demand compounds through 2033, outpacing GDP across Product Form.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Form moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.18BLarge & growingTAM by 2033 at 5.8% CAGR
$2.57BServiceable nowreachable with today’s model
$497MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.82BBear3.8% CAGR
$6.18BBase5.8% CAGR
$7.92BBull7.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Purity Grade optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Hing (Asafoetida) Market — a $9.62B market by 2033. Plan: grow share from 7.9% to 15.7%.
Market size · 2033$9.62Btotal addressable
Market CAGR7.4%2027–2033
Target share15.7%from 7.9% today
Revenue ambition$1.51Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.9% | 15.7% | On track |
| Revenue | $703M | $1.51B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 31.3% | 40.4% | On track |
| Customer retention | 86.5% | 97.0% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Form
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Purity Grade capability
A defensible second engine — invest in Purity Grade to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Form share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Purity Grade
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $157M capacity & capability investment
- Greenlight bolt-on M&A in Purity Grade
- Authorise North America expansion plan
- Fund R&D program for Product Form leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAhead
- Input-cost & supply riskBehind
- Regulatory / policy changeOn track
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Hing (Asafoetida) Market conversation — a $5.67B market you can size, segment and defend in minutes.
Market size · 2033$5.67Btotal opportunity
Growth10.7%CAGR to 2033
Addressable buyers1,437+accounts in scope
Typical ROI7.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Form
Goal Grow share in Product Form
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.3×return on cost, year one
< 4 mopayback period
$64K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Synthite Industries Ltd.Kancor Ingredients Ltd.Arjuna Natural Extracts Ltd.Vidya Herbs Pvt. Ltd.Herbal Hills Pvt. Ltd.Indus Organics Pvt. Ltd.Aarkay Food Products Pvt. Ltd.Sresta Natural Bioproducts Pvt. Ltd.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Hing (Asafoetida) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Hing (Asafoetida) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Hinge Arm Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportHinge Bar Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportHinge Lid Packing Machine Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportHinge Support Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportHinged Windows Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportHinokitiol (CAS 38094-79-0) Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportHip & Knee Implant Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportHip & Knee Implants Market
Market size, share, segmentation and regional forecast.
$566M market · 2025 base year
View reportHip and Joint Supplement for Pet Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportHip Boards Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportHip Chairs Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportHip Impaction Automated System Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.